Oncolytics Biotech Inc T.ONC

usa newsgroup article re: pela and pancreatic cancer

[itntdf]

https://usanewsgroup.com/2022/11/27/market-uncertainty-is-creating-opportunities-that-have-somehow-been-overlooked/

[lonc17]

This USA Newsgroup piece is a paid adverstiment by ONC. ONC paid for these kind of advertisments much more frequently when Brad Thompson was CEO. IMO, this significantly diminishes the liklihood of any near term buyout or partnership. Hard to take a small cap company seriously when they pump their own SP with cheap advertising. 

[itntdf]

there is a fake it til you make it component of paid advertising but that's the nature of being a small company and trying to get your message out. seems oncy is now on the verge of making it at which point the product/company will speak for itself.

[lonc17]

But they really need to show a little self-respect.  I find it hard to imagine that Matt is negotiating hard with Big Pharma while at the same time promoting the company like it's a penny stock on the OTC.

[itntdf]

self-promotion doesn't necessarily equate to no self-respect.  don't get the feel matt is groveling. this is not sbf screwing the pooch.

[westcoast1000]

ONCY and pela are hard for most people to understand, even at a superficial level. Its value and progress are completely tied to scientific papers and posters. That is all we have to communicate to possible retail or institutional investors. In the past, when the strategy was directly killing the tumors with the virus, it was easier to conceptualize and provide a narrative for the product. Now it